Drug
Alimatravir clinical trials
Also written MK-8527.
- studies test it
- 16
- open now
- 3
- in phase 3
- 2
- first study started
- 2019
Keep track of what changes. Save the alimatravir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
- MK-8527
- 15
Studies by the year they started
16 studies that test it; most in 2025 (7)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 7 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 12
- Phase 2
- 2
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 16 · Other 0
Often tested with
Tested in the same studies.
Methadone (1) · Levonorgestrel (1) · Ethinyl Estradiol (1) · Rifampin (1)
Studies
Open first, then newest update. How each study uses alimatravir is read from its arms, and is right about nine times in ten.
Testing it · 16
- A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)RecruitingPhase 3Merck Sharp & Dohme LLCNCT07071623Written as MK-8527
- A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)Not yet recruitingPhase 2Merck Sharp & Dohme LLCNCT07850609Written as Alimatravir
- A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)Not yet recruitingPhase 1Merck Sharp & Dohme LLCNCT07600775Written as MK-8527
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)Active, not recruitingPhase 3Merck Sharp & Dohme LLCNCT07044297Written as MK-8527
- A Clinical Study of MK-8527 in Healthy Participants (MK-8527-021)Active, not recruitingPhase 1Merck Sharp & Dohme LLCNCT07661108Written as MK-8527
- A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527 on Levels of Methadone (MK-8527-020)CompletedPhase 1Merck Sharp & Dohme LLCNCT07528508Written as MK-8527
- A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)CompletedPhase 1Merck Sharp & Dohme LLCNCT06580587Written as MK-8527
- A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)CompletedPhase 1Merck Sharp & Dohme LLCNCT07025551Written as MK-8527
- A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)CompletedPhase 1Merck Sharp & Dohme LLCNCT06295796Written as MK-8527
- A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)CompletedPhase 1Merck Sharp & Dohme LLCNCT07063238Written as MK-8527
- Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)CompletedPhase 2Merck Sharp & Dohme LLCNCT06045507Written as MK-8527
- A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)CompletedPhase 1Merck Sharp & Dohme LLCNCT06893081Written as MK-8527
- A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)CompletedPhase 1Merck Sharp & Dohme LLCNCT06826989Written as [14C]MK-8527
- MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)CompletedPhase 1Merck Sharp & Dohme LLCNCT05494736Written as MK-8527
- A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)CompletedPhase 1Merck Sharp & Dohme LLCNCT06783192Written as MK-8527
- A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002)CompletedPhase 1Merck Sharp & Dohme LLCNCT03615183Written as MK-8527
Given in every arm · 1 — alimatravir is usual care beside what is tested
Codes
What other systems call alimatravir · ClinicalTrials.gg INT016620
- UNII (FDA) G2CS3JB82TALIMATRAVIROne source FDA
- NCI Thesaurus C224709AlimatravirOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | G2CS3JB82T | ALIMATRAVIR | One source FDA |
| NCI Thesaurus | C224709 | Alimatravir | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.